Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 11/20 | 0.60 |
| ▸ | F2 | P00734 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL6770954 | 0.98 | F10 (0.63) | F10F2MAPTL3MBTL1KMT2A | |
| Trifluoroacetic Acid SCHEMBL6771038 | 0.87 | ROCK1 (0.48) | F10F2OPRM1OPRD1LMNA | |
| Trifluoroacetic Acid SCHEMBL6765933 | 0.86 | F10 (0.68) | F10F2MAPTL3MBTL1KMT2A | |
| Trifluoroacetic Acid SCHEMBL6771145 | 0.84 | ROCK1 (0.48) | F10F2 | |
| Trifluoroacetic Acid SCHEMBL6769129 | 0.83 | F10 (0.53) | F10F2L3MBTL1KMT2AMEN1 | |
| Trifluoroacetic Acid SCHEMBL3910305 | 0.81 | F10 (0.90) | F10F2 | |
| Trifluoroacetic Acid SCHEMBL6765882 | 0.80 | F10 (0.56) | F10F2KMT2AMEN1ALDH1A1 | |
| Trifluoroacetic Acid SCHEMBL6775232 | 0.80 | RAD52 (0.42) | F10MAPTL3MBTL1ALDH1A1 | |
| Trifluoroacetic Acid SCHEMBL6775993 | 0.78 | F10 (0.42) | F10L3MBTL1ALDH1A1 | |
| Trifluoroacetic Acid SCHEMBL6770182 | 0.77 | NPC1 (0.42) | F10L3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6825181-B1 | ORALLY ADMINISTRATED TO EXHIBIT A STRONG ANTICOAGULANT EFFECT BY INHIBITING ACTIVATED BLOOD- COAGULATION FACTOR X | AJINOMOTO CO., INC. (JP) | 2004-11-30 | — | — | US | disclosed |
| EP-1065200-A1 | AMINOISOQUINOLINE DERIVATIVES | Ajinomoto Co., Inc. (JP) | 2001-01-03 | — | — | EP | disclosed |